Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone versus metformin for nonalcoholic steatohepatitis
IRCT201105026361N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of pioglitazone and metformin in metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD) (2 arms), sponsored by Kashan University of Medical Sciences. Started Mar 2011; status: completed.
02
Drugs
pioglitazonemetformin
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT201105026361N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201105026361N1.